Login / Signup

Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group.

Kunanya SuwannayingChalinee MonsereenusornPiya RujkijyanontPiti TechavichitKamon PhuakpetPongpak PongphitchaSu-On ChainansamitThirachit ChotsampancharoenAngkana WinaichatsakChanchai TraivareeLalita SathitsamitphongSomjai KanjanapongkulPatcharee KomvilaisakKleebsabai SanpakitApichat PhotiaPanya SeksarnSurapon WiangnonSuradej Hongengnull null
Published in: Pediatric blood & cancer (2022)
A combination of HSCT and cis-RA successfully improved the outcomes of patients with HR-NBL in immunotherapy inaccessible settings.
Keyphrases
  • rheumatoid arthritis
  • palliative care
  • hematopoietic stem cell
  • metabolic syndrome
  • systemic lupus erythematosus
  • young adults
  • interstitial lung disease